C3 ( CTHR ) Diamond in the rough? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : C3 ( CTHR ) Diamond in the rough?

CTHR 0.400

+263.6%

Oct 31 12:16 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: froland who wrote (51)	1/8/1998 1:54:00 AM
From: Leslie S. Feinberg	of 226

froland; My understanding is that the tests C3 did were straight up and that the jewelers knew what they were being asked to distinguish. Also, the national evening news feature (Jennings) a couple of weeks ago used an interview with a "prominent" gemnologist who said the moissanite gems were indistinguishable from the real thing without an instrument. The company is supposedly pushing the launch of the instrument and the moissanite stones at the same time because they are so concerned to avoid any FTC problems which they feel could well occur if they didn't offer reliable technology to differentiate the stones. So convincing a substitute is the C3 gem said to be. I find it hard to believe that the double refraction phenomenon reported is so obvious that all one needs to differentiate the stones is a 10X loupe. Les

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next